Skip to Content
You are currently on the new version of our website. Access the old version .

17 Results Found

  • Article
  • Open Access
18 Citations
6,880 Views
18 Pages

6 September 2020

As liver hepatocellular carcinoma (LIHC) has high morbidity and mortality rates, improving the clinical diagnosis and treatment of LIHC is an important issue. The advent of the era of precision medicine provides us with new opportunities to cure canc...

(This article belongs to the Special Issue Molecular Biomarkers in Solid Tumors)
  • Article
  • Open Access
14 Citations
3,729 Views
21 Pages

Pan-Cancer Analysis and Experimental Validation of SOX4 as a Potential Diagnosis, Prognosis, and Immunotherapy Biomarker

  • Xinna Deng,
  • Yashu Wang,
  • Hao Guo,
  • Qian Wang and ,
  • Shuting Rao and
  • Haijiang Wu
  • + 1 author+ 0 author

31 October 2023

Introduction: SOX4 plays an important role in tumorigenesis and cancer progression. The role of SOX4 in pan-cancer and its underlying molecular mechanism in liver hepatocellular carcinoma (LIHC) are not fully understood. In this study, a comprehensiv...

(This article belongs to the Section Cancer Causes, Screening and Diagnosis)
  • Article
  • Open Access
5 Citations
2,990 Views
11 Pages

Comprehensive Analysis of NKX3.2 in Liver Hepatocellular Carcinoma by Bigdata

  • An-Na Bae,
  • Jongwan Kim,
  • Jong-Ho Park,
  • Jae-Ho Lee and
  • Euncheol Choi

6 October 2023

Background and Objectives: The gene NKX3.2 plays a role in determining cell fate during development, and mutations of NKX3.2 have been studied in relation to human skeletal diseases. However, due to the lack of studies on the link between NKX3.2 and...

(This article belongs to the Section Gastroenterology & Hepatology)
  • Article
  • Open Access
13 Citations
5,269 Views
20 Pages

Implications of Stemness Features in 1059 Hepatocellular Carcinoma Patients from Five Cohorts: Prognosis, Treatment Response, and Identification of Potential Compounds

  • Haoming Mai,
  • Haisheng Xie,
  • Mengqi Luo,
  • Jia Hou and ,
  • Jiaxuan Chen,
  • Jinlin Hou and
  • De-ke Jiang
  • + 2 authors+ 0 author

23 January 2022

Cancer stemness has been reported to drive hepatocellular carcinoma (HCC) tumorigenesis and treatment resistance. In this study, five HCC cohorts with 1059 patients were collected to calculate transcriptional stemness indexes (mRNAsi) by the one-clas...

(This article belongs to the Special Issue Bioinformatics, Big Data and Cancer)
  • Article
  • Open Access
2 Citations
2,346 Views
18 Pages

9 October 2025

Hepatocellular carcinoma (HCC) ranks among the most prevalent malignancies globally. Although treatment strategies have improved, the prognosis for patients with advanced HCC remains unfavorable. Tumor-associated macrophages (TAMs) play a dual role,...

(This article belongs to the Section Molecular Informatics)
  • Article
  • Open Access
19 Citations
5,362 Views
17 Pages

Identifying Interaction Clusters for MiRNA and MRNA Pairs in TCGA Network

  • Xinqing Dai,
  • Lizhong Ding,
  • Hannah Liu,
  • Zesheng Xu and ,
  • Hui Jiang,
  • Samuel K Handelman and
  • Yongsheng Bai
  • + 2 authors+ 0 author

11 September 2019

Existing methods often fail to recognize the conversions for the biological roles of the pairs of genes and microRNAs (miRNAs) between the tumor and normal samples. We have developed a novel cluster scoring method to identify messenger RNA (mRNA) and...

(This article belongs to the Special Issue Selected Papers from the International Conference on Intelligent Biology and Medicine (ICIBM 2019))
  • Article
  • Open Access
2 Citations
975 Views
36 Pages

11 December 2025

Background and Objectives: Although beaded filament structural protein 1 (BFSP1) may be involved in oncogenic mechanisms, its clinical relevance and functional role in liver hepatocellular carcinoma (LIHC) remain unclear. This study examined the prog...

(This article belongs to the Section Pharmacology)
  • Article
  • Open Access
3 Citations
1,214 Views
21 Pages

Background: Hepatocellular carcinoma (HCC) stands as a prevalent global health issue with increasing incidence and mortality rates. Hepatocellular carcinoma (HCC) exhibits profound molecular and clinical heterogeneity, which limits the effectiveness...

(This article belongs to the Section Molecular Genetics and Genetic Diseases)
  • Article
  • Open Access
2 Citations
2,895 Views
19 Pages

Application of Graph Models to the Identification of Transcriptomic Oncometabolic Pathways in Human Hepatocellular Carcinoma

  • Sergio Barace,
  • Eva Santamaría,
  • Stefany Infante,
  • Sara Arcelus and ,
  • Jesus De La Fuente,
  • Enrique Goñi,
  • Ibon Tamayo,
  • Idoia Ochoa,
  • Miguel Sogbe and
  • Josepmaria Argemi
  • + 8 authors+ 3 authors

Whole-tissue transcriptomic analyses have been helpful to characterize molecular subtypes of hepatocellular carcinoma (HCC). Metabolic subtypes of human HCC have been defined, yet whether these different metabolic classes are clinically relevant or d...

(This article belongs to the Special Issue Signal Transduction to Transcription Factors in Health and Disease—Honorary Special Issue Commemorating the Work of Prof. Athanasios G. Papavassiliou)
  • Article
  • Open Access
6 Citations
4,230 Views
19 Pages

The Role of NCS1 in Immunotherapy and Prognosis of Human Cancer

  • Gen-Chun Wang,
  • Xin Gan,
  • Yun-Qian Zeng,
  • Xin Chen and ,
  • Hao Kang,
  • Shuai-Wen Huang and
  • Wei-Hua Hu
  • + 2 authors+ 0 author

The Neural Calcium Sensor1 (NCS1) is a crucial protein that binds to Ca2+ and is believed to play a role in regulating tumor invasion and cell proliferation. However, the role of NCS1 in immune infiltration and cancer prognosis is still unknown. Our...

(This article belongs to the Special Issue Mechanisms of Cell Death in Cancer Cells: A New Therapeutic Opportunity)
  • Article
  • Open Access
40 Views
13 Pages

13 November 2026

Background/Objectives: Hepatocellular carcinoma (HCC) is a highly heterogeneous malignancy comprising distinct molecular subtypes with variable clinical behavior. Among them, the stemness-high (STM) subtype is characterized by elevated cancer stemnes...

(This article belongs to the Special Issue Systemic Therapy in Hepatocellular Carcinoma: Current Challenges and Future Directions)
  • Article
  • Open Access
504 Views
24 Pages

4 August 2026

Hepatocellular carcinoma (HCC) is one of the most frequent and lethal malignancies worldwide, with substantial molecular and clinical heterogeneity that complicates prognostic assessment. We aimed to identify molecular subgroups with distinct prognos...

(This article belongs to the Section Bioinformatics)
  • Article
  • Open Access
2 Citations
2,060 Views
19 Pages

18 August 2025

The overall survival of hepatocellular carcinoma (HCC) remains poor, highlighting the need for better prognostic tools. Nucleotide metabolism fuels tumor progression, while the immune microenvironment dictates therapy response, but integrated models...

(This article belongs to the Section Bioinformatics)
  • Article
  • Open Access
6 Citations
3,589 Views
30 Pages

27 December 2022

Butyrate, one of the major products of the gut microbiota, has played notable roles in diverse therapies for multiple tumors. Our study aimed to determine the roles of genes that modulate butyrate metabolism (BM) in predicting the clinical prognosis...

(This article belongs to the Section Bioinformatics and Systems Biology)
  • Article
  • Open Access
10 Citations
3,386 Views
23 Pages

5 September 2023

Background: The liver plays an important role in maintaining copper homeostasis. Copper ion accumulation was elevated in HCC tissue samples. Copper homeostasis is implicated in cancer cell proliferation and angiogenesis. The potential of copper homeo...

(This article belongs to the Special Issue Clinical, Translational and Experimental Pharmacotherapeutics Advances)
  • Article
  • Open Access
12 Citations
4,943 Views
20 Pages

Mitochondria-Associated Endoplasmic Reticulum Membrane (MAM) Is a Promising Signature to Predict Prognosis and Therapies for Hepatocellular Carcinoma (HCC)

  • Yuyan Chen,
  • Senzhe Xia,
  • Lu Zhang,
  • Xueqian Qin and ,
  • Zhengyi Zhu,
  • Tao Ma,
  • Shushu Lu,
  • Jing Chen,
  • Xiaolei Shi and
  • Haozhen Ren
  • + 5 authors+ 0 author

24 February 2023

Background: The roles of mitochondria and the endoplasmic reticulum (ER) in the progression of hepatocellular carcinoma (HCC) are well established. However, a special domain that regulates the close contact between the ER and mitochondria, known as t...

(This article belongs to the Special Issue Clinical, Translational and Experimental Pharmacotherapeutics Advances)
  • Article
  • Open Access
1,860 Views
19 Pages

Stratification of Hepatocellular Carcinoma Using N6-Methyladenosine

  • Nan Wang,
  • Jia-Xin Shi,
  • Matthias Bartneck,
  • Edgar Dahl and
  • Junqing Wang

2 July 2025

Background: The N6-methyladenosine (m6A) modification of eukaryotic mRNA is the most prevalent of such epigenetic modifications and has recently been identified as a potential player in the pathogenesis and progression of hepatocellular carcinoma (HC...

(This article belongs to the Section Cancer Immunology and Immunotherapy)